Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading

Division of Cardiology, Johns Hopkins Medical Institutions, Ross 858, 720 Rutland Ave, Baltimore, MD 21205, USA.
Circulation (Impact Factor: 14.95). 11/2011; 125(2):289-97. DOI: 10.1161/CIRCULATIONAHA.111.051540
Source: PubMed

ABSTRACT Right ventricular failure from increased pulmonary vascular loading is a major cause of morbidity and mortality, yet its modulation by disease remains poorly understood. We tested the hypotheses that, unlike the systemic circulation, pulmonary vascular resistance (R(PA)) and compliance (C(PA)) are consistently and inversely related regardless of age, pulmonary hypertension, or interstitial fibrosis and that this relation may be changed by elevated pulmonary capillary wedge pressure, augmenting right ventricular pulsatile load.
Several large clinical databases with right heart/pulmonary catheterization data were analyzed to determine the R(PA)-C(PA) relationship with pulmonary hypertension, pulmonary fibrosis, patient age, and varying pulmonary capillary wedge pressure. Patients with suspected or documented pulmonary hypertension (n=1009) and normal pulmonary capillary wedge pressure displayed a consistent R(PA)-C(PA) hyperbolic (inverse) dependence, C(PA)=0.564/(0.047+R(PA)), with a near-constant resistance-compliance product (0.48±0.17 seconds). In the same patients, the systemic resistance-compliance product was highly variable. Severe pulmonary fibrosis (n=89) did not change the R(PA)-C(PA) relation. Increasing patient age led to a very small but statistically significant change in the relation. However, elevation of the pulmonary capillary wedge pressure (n=8142) had a larger impact, significantly lowering C(PA) for any R(PA) and negatively correlating with the resistance-compliance product (P<0.0001).
Pulmonary hypertension and pulmonary fibrosis do not significantly change the hyperbolic dependence between R(PA) and C(PA), and patient age has only minimal effects. This fixed relationship helps explain the difficulty of reducing total right ventricular afterload by therapies that have a modest impact on mean R(PA). Higher pulmonary capillary wedge pressure appears to enhance net right ventricular afterload by elevating pulsatile, relative to resistive, load and may contribute to right ventricular dysfunction.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The effect of pulmonary venous hypertension (PVH) on the pulmonary circulation is extraordinarily variable, ranging from no impact on pulmonary vascular resistance (PVR) to a marked increase. The reasons for this are unknown. Both acutely reversible pulmonary vasoconstriction and pathological remodeling (especially medial hypertrophy and intimal hyperplasia) account for increased PVR when present. The mechanisms involved in vasoconstriction and remodeling are not clearly defined, but increased wall stress, especially in small pulmonary arteries, presumably plays an important role. Myogenic contraction may account for increased vascular tone and also indirectly stimulate remodeling of the vessel wall. Increased wall stress may also directly cause smooth muscle growth, migration, and intimal hyperplasia. Even long-standing and severe pulmonary hypertension (PH) usually abates with elimination of PVH, but PVH-PH is an important clinical problem, especially because PVH due to left ventricular noncompliance lacks definitive therapy. The role of targeted PH therapy in patients with PVH-PH is unclear at this time. Most prospective studies indicate that these medications are not helpful or worse, but there is ample reason to think that a subset of patients with PVH-PH may benefit from phosphodiesterase inhibitors or other agents. A different approach to evaluating possible pharmacologic therapy for PVH-PH may be required to better define its possible utility.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The age at diagnosis of pulmonary arterial hypertension (PAH) and the prevalence of cardiovascular (CV) risk factors are increasing. We sought to determine whether the response to drug therapy was influenced by CV risk factors in PAH patients. We studied consecutive incident PAH patients (n = 146) between January 1, 2008, and July 15, 2011. Patients were divided into two groups: the PAH-No CV group included patients with no CV risk factors (obesity, systemic hypertension, type 2 diabetes mellitus, permanent atrial fibrillation, mitral and/or aortic valve disease, and coronary artery disease), and the PAH-CV group included patients with at least one. The response to PAH treatment was analyzed in all the patients who received PAH drug therapy. The PAH-No CV group included 43 patients, and the PAH-CV group included 69 patients. Patients in the PAH-No CV group were younger than those in the PAH-CV group (P < 0.0001). In the PAH-No CV group, 16 patients (37%) improved on treatment and 27 (63%) did not improve, compared with 11 (16%) and 58 (84%) in the PAH-CV group, respectively (P = 0.027 after adjustment for age). There was no difference in survival at 30 months (P = 0.218). In conclusion, in addition to older age, CV risk factors may predict a reduced response to PAH drug therapy in patients with PAH.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pulsatile afterload describes the compliance (Cp) of the pulmonary artery (PA) and the coupling of the right ventricle (RV) contraction to the PA afterload. Recent studies have demonstrated the important role of pulsatile afterload in the progression of RV impairment and the prognostic value of Cp in pulmonary hypertension (PH). Previous studies have observed that pulmonary vascular resistance (PVR) and Cp are coupled via an inverse linear relationship (RC). There is an unsolved controversy about the role that the site of the obstruction in the pulmonary vascular bed plays on this RC relationship. In a series of relatively small studies, different authors stated that RC is nearly constant. Tedford et al. have recently challenged the concept of a fixed RC in PH due to left heart failure. Most of the studies which have compared pulsatile afterload properties in pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH),with small number of patients and significant different mean arterial pressure (mP), have observed contradictory results. Recent studies have shown that the RC time can be shorter in CTEPH caused by proximal obstruction compared to distal obstruction. Nevertheless there is currently no feasiblemethod in clinical practice to determine the real amount of obstruction in the distal pulmonary arteries and this discrimination of proximal and distal obstruction in the classification of CTEPH has been abandoned in the current PH guidelines. We hypothesized that the different distribution of the vascular remodeling in PAH and CTEPH impacts on RC time independently of mP. The aim of this study was to compare the hemodynamic pulsatile afterload in a large population of PAH and CTEPH patients.
    International Journal of Cardiology 02/2015; 181(1):232-234. DOI:10.1016/j.ijcard.2014.11.118 · 6.18 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014